XML 66 R52.htm IDEA: XBRL DOCUMENT v3.26.1
Schedule of Outstanding Warrants (Details) (Parenthetical) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Jul. 26, 2024
Apr. 18, 2024
Class of Warrant or Right [Line Items]        
Public warrant redemption description The Company may redeem the outstanding Public Warrants for $0.12 per warrant upon at least 30 days’ prior written notice of redemption given after the warrants become exercisable, if the reported last sale price of the common stock equals or exceeds $2,160.00 per share (as adjusted for stock dividends, sub-divisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing after the warrants become exercisable and ending on the third trading day before the Company sends the notice of redemption to the warrant holders. Upon issuance of a redemption notice by the Company, the warrant holders may, at any time after the redemption notice, exercise the public warrants on a cashless basis.      
Redemption of outstanding warrants per share $ 0.12      
Number of shares purchased 5,026,613 910,299 58,235 16,375
Received dross proceeds $ 4,803    
Redemption of Warrants [Member] | Share Price Equal Or Less Ten Point Zero Rupees Per Dollar [Member]        
Class of Warrant or Right [Line Items]        
Class of warrants, redemption notice period 30 days      
Redemption of Warrants [Member] | Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member]        
Class of Warrant or Right [Line Items]        
Share Price $ 2,160,000.00      
Series A Warrants [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased 33,335,000 60,418,000    
Warrants exercise price $ 8.40 $ 18.24    
Received dross proceeds $ 300 $ 1,100    
Series B Warrants [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased 22,275,000 68,335,000    
Warrants exercise price $ 24.00 $ 18.24    
Gross proceeds $ 500 $ 1,200    
Series B Warrants to Purchase Common Stock [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased [1] 57,451,000    
Warrants exercise price $ 18.24 $ 18.24    
Warrants outstanding 0      
Series B-1 Warrants [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased 62,086,000 27,082,000    
Warrants exercise price $ 8.40 $ 18.24    
Gross proceeds $ 500 $ 500    
Series C-1 Warrants [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased 4,167,000 47,936,000    
Warrants exercise price $ 24.00 $ 18.24    
Gross proceeds $ 100 $ 900    
Series C-1 Warrants [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased 41,668,000      
Warrants exercise price $ 8.40      
Gross proceeds $ 400      
Series D Warrants [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased 70,835,000      
Warrants exercise price $ 8.40      
Gross proceeds $ 600      
Deemed dividend $ 1,700      
Series E Warrants and Series F Warrants [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased 341,672,000      
Warrants exercise price $ 8.40      
Gross proceeds $ 2,800      
Series G Pre-Funded Warrants [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased 227,334,000      
Warrants exercise price $ 0.012      
Gross proceeds $ 3,000      
Series I Pre-Funded Warrants [Member]        
Class of Warrant or Right [Line Items]        
Number of shares purchased 1,528,000,000      
Warrants exercise price $ 0.001      
Gross proceeds $ 1,500      
[1] Series B warrants to purchase 22,275 shares of common stock were exercised at a reduced exercise price of $24.00 in connection with the May Inducement Offer. Pursuant to the issuance of common stock per the Series B warrant exercises, the Company received gross proceeds of approximately $0.5 million. During the year ended December 31, 2024, Series B warrants to purchase 68,335 shares of common stock were exercised at $18.24 per share and the Company received gross proceeds of approximately $1.2 million.